Episode

Zaynich: A New Weapon Against MDR Gram-Negatives

Podcast: Diabetic Foot Files
Published: Jun 23, 2026
Duration seconds: 1042
Processing state: not_requested
Canonical source: https://gdhutche.podbean.com/e/zaynich-a-new-weapon-against-mdr-gram-negatives/
Audio: https://mcdn.podbean.com/mf/web/ym3c5fhr8y8atzqv/Zaynich-_Cefepime_and_Zidebactam_-cexb2u-Optimized.mp3
JSON: /v1/public/podcasts/diabetic-foot-files-7302870/episodes/zaynich-a-new-weapon-against-mdr-gram-negatives
Markdown: /podcast/diabetic-foot-files-7302870/zaynich-a-new-weapon-against-mdr-gram-negatives.md

Actions

POST https://stenobird.com/v1/public/podcasts/diabetic-foot-files-7302870/episodes/zaynich-a-new-weapon-against-mdr-gram-negatives/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/diabetic-foot-files-7302870/zaynich-a-new-weapon-against-mdr-gram-negatives.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of Diabetic Foot Files, Dr. G explores Zaynich (cefepime + ZD-bactam), a newly FDA-approved IV antibiotic designed to overcome multi-drug resistant gram-negative infections. He explains the drug's dual-target mechanism, its potential role in limb salvage for severe diabetic foot infections, common side effects, dosing, current FDA indications, and when to involve infectious disease specialists.Listeners will learn why this combination may be a game-changer for difficult-to-treat infections, the importance of antibiotic stewardship, and practical considerations for use in wound care and limb salvage scenarios.